Cargando…
Anticoagulation as a therapeutic strategy for hospitalised patients with COVID-19
The COVID-19 pandemic has devastated the global community and continues to cause significant morbidity and mortality worldwide. The development of effective vaccines has represented a major step towards reducing transmission and illness severity but significant challenges remain, particularly in reg...
Autores principales: | Cullivan, S., Sholzberg, M., Áinle, F.Ní, Kevane, B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752165/ http://dx.doi.org/10.1016/j.tru.2022.100097 |
Ejemplares similares
-
Characteristics of chronic thromboembolic pulmonary hypertension in Ireland
por: Cullivan, Sarah, et al.
Publicado: (2021) -
An optimized protocol to isolate quiescent washed platelets from human whole blood and generate platelet releasate under clinical conditions
por: Weiss, Luisa, et al.
Publicado: (2023) -
Anticoagulation in hospitalized patients with COVID-19
por: Baumann Kreuziger, Lisa, et al.
Publicado: (2022) -
Anticoagulation practice patterns in COVID‐19: A global survey
por: Rosovsky, Rachel P., et al.
Publicado: (2020) -
Platelets, extracellular vesicles and coagulation in
pulmonary arterial hypertension
por: Cullivan, Sarah, et al.
Publicado: (2021)